Methods of treatment employing prolonged continuous infusion of Belinostat

• 收藏
• 分享

专利权人:

TopoTarget A/S

发明人:

Nissen, Nis,Sehested, Maxwell,Jensen, Peter Buhl

申请号：

AU2009220942

公开号：

AU2009220942A8

申请日:

2009.03.06

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

The present invention relates generally to the treatment of diseases and disorders that are mediated by histone deacetylase (HDAC), for example, cancer, with Belinostat (also known as (E)-N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide； PXD101； and PX 105684), and more particularly, to improvement treatments of such diseases (for example, cancers, for example, leukemias), which employ prolonged continuous infusion (e.g., prolonged continuous intravenous infusion) of Belinostat

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/